“…MATERIAL/METHODS: Forty New-Zealand rabbits were randomized into 4 groups: group 1 classifying animals with carotid shunt and patent contralateral carotid artery; group 2 shunt and occlusion of the contralateral carotid artery; group 3 no-shunt and patent contralateral carotid artery; and group 4 no-shunt and occlusion of the contralateral carotid artery. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Additionally 60 generic sildenafils from 49 companies were released with termination of sildenafil patent in Korea, 2012 and 160 generic tadalafils from 64 companies were released with termination of tadalafil patent in Korea, 2015. …”
Enlace del recurso
Enlace del recurso

“…METHODS: To identify technologies that have potential future application for vaginal ring adherence measurement, a comprehensive literature search was conducted that covered a number of biomedical and public health databases, including PubMed, Embase, POPLINE and the Web of Science. Published patents and patent applications were also searched. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…We considered four different sets of candidate predictors, each including four quantitative structural variables (for example, mean glomerular tuft area, cortical density of patent glomeruli and two of the principal components from the correlation matrix of six fractional cortical areas–interstitium, atrophic tubule, intact tubule, blood vessel, sclerotic glomerulus, and patent glomerulus) along with 13 potentially confounding demographic and clinical variables (such as race, age, diagnosis, and baseline eGFR, quantitative proteinuria and BMI). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…A total of 335 coronary ISR lesions were treated with DEBs. The 1-year patent coronary artery group was defined as those with negative noninvasive examinations and no clinical symptoms, or those with no angiographic restenosis. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Healthy controls were also included. 400 cases and 400 controls were thus identified; preterms having patent ductus arteriosus and patent foramen ovale and those with acquired heart defects were excluded. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODOLOGY: Therapies assessed by the Scottish Medicines Consortium (SMC) in the UK between 1 January 2013 and 1 June 2016 were identified; only in-patent therapies were included in the analysis (to avoid the impact of price erosion post patent expiry); results were grouped according to annual cost per patient (whether considered high-cost, i.e., >£2,500 per patient per year, or not) and the size of the UK target population [whether considered orphan (<32,000 patients per year), ultra-orphan (<1,000 patients per year), or not]. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…MGP provides unequivocal physical proof of a patent meibum outflow tract through the natural orifice, and may promote glandular growth in part by direct mechanical establishment of a patent duct/orifice system.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…A bubble echo confirmed a patent foramen ovale. A leptospirosis and a vasculitis screen were both negative. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In group 1, the PCA phase difference values (autoregulatory parameter) were significantly higher in the subgroup with patent PCoAs, compared to those without. In group 2, the MCA phase difference values were higher in the subgroup with patent ACoA, compared to those without. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Biomarker ratios (occluded/patent status) trended high in patients with poorly controlled diabetes (MYPT ratio: 1.7 [1.0–3.0] vs. 1.1 [0.7–1.3], p = 0.06; galectin-3: 1.6 [1.3–3.4] vs. 1.1 [0.8–1.9], p = 0.05). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Thus, we analysed Breg and Treg frequencies in peripheral blood from Ghanaian uninfected endemic normals (EN), lymphedema (LE), asymptomatic patent (CFA+MF+) and latent (CFA+MF-) W. bancrofti-infected individuals as well as individuals who were previously infected with W. bancrofti (PI) but had cleared the infection due to the administration of ivermectin (IVM) and albendazole (ALB). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Results: The study populations consisted of 12 preterm infants with NEC but without patent ductus arteriosus (PT-NEC), seven preterm infants with NEC and patent ductus arteriosus (PDA-NEC), and 17 infants with NEC and congenital heart disease (CHD-NEC). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The ability of these ELISAs to identify animals with latent and/or patent forms of MAP infection was investigated using serum from naturally infected cattle (n = 88) and non-infected control animals (n = 67). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Fecal samples of the cats were examined to confirm the presence of patent (adult) nematode infections prior to treatment at 28 dpi and to monitor the larval excretion. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In 84.9% the bypass appeared definitively, in 5.7% uncertainly and in 9.4% not patent according to early post-operative CTA. MR-TOF suggested definitive bypass patency in 86.8% 3 months after surgery and in 93.5% 6–12 months after surgery. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The most frequent echocardiographic abnormalities in infants of diabetic mothers were patent ductus arteriosus (PDA) (31.75%), patent foramen ovale (PFO) (31.75%), and atrial septal defect (ASD) (23.64%). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…RESULTS: Among the six grafts, five were deemed patent (patency rate of >83%), with one occluded 20 weeks after implantation. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In 2015, Diane Van Tasell patented a method for measuring an audiogram when the precise signal level was unknown (patent US 8,968,209 B2). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…According to logistic predictor analysis of 30-day mortality, significant factors showed patent type (OR 10.89, 95% CI 1.66–20.31) and malperfusion (OR 4.63, 95% CI 1.74–12.32). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso